| |
Urotensin II, human  |
|
|
| Cat. No. |
Size |
Price |
Figures |
|---|
RP10096-0.5 mg
| 0.5 mg | $ 61.75 | HPLC: 20060721145613 (PDF)
MS: 20060721145553 (PDF)
DATASHEET: 20080130202322 (DOC)
MSDS: 20080924035043 (PDF)
References:
- Albertin G, et al. Urotensin-II and UII-receptor expression and function in the rat adrenal cortex. Int. J. Mol. Med. Jun 2006; 17(6): 1111-1115.
- Gruson D, et al. Circulating urotensin II levels in moderate to severe congestive heart failure: Its relations with myocardial function and well established neurohormonal markers. Peptides. Jun 2006; 27(6): 1527-1531.
- Rdzanek A, et al. Exercise urotensin II dynamics in myocardial infarction survivors with and without hypertension. Int. J. Cardiol. Jun 2006; 110(2): 175-178.
|
|---|
| Full Name | |
| Alias |
U II , UrotensinII; Urotensin 2; Urotensin2 |
Sequence
(one-letter code) |
ETPDCFWKYCV | Sequence
(three-letter code) | {GLU}{THR}{PRO}{ASP}{CYS}{PHE}{TRP}{LYS}{TYR}{CYS}
{VAL} |
|---|
| Chemical Bridge | Cys5-Cys10 |
|---|
| Description | The orphan receptor GPR14 has been found to be expressed predominantly in cardiovascular tissue and many serve as a receptor for urotensin II (human). Urotensin II (human) binds with high affinity to recombinant GPR14. It is found within both vascular and cardiac tissue. Urotensin II vasoconstrictive potency is reported to be an order of magnitude greater than that of endothelin-1 (ET-1), which would make it the most potent mammalian vasoconstrictor identified to date. Recently, our research data has shown that urotensin II is involved in the development of rat cardiac hypertrophy: Contractile response to human U II in rat and human pulmonary arteries was increased by endothelial factors, vascular tone, and the onset of pulmonary hypertension. |
|---|
| Solubility | The peptide is soluble in water. The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weigh out a smaller portion of the contents. |
|---|
| Formula | C64H85N13O18S2 |
|---|
| M.W. | 1388.57 |
|---|
| Purity | > 95% |
|---|
| Storage | Before use, store the peptide in the DRY form at 0°C - 5°C. For best and most repeatable results, rehydrate the peptide immediately before use. Do not re-freeze any unused portions. |
| * For Non-Clinical Research Use Only *
Our customer service is available 24 hours a day, Monday through Friday. You may contact us any time for assistance.
|
|
